Loading...

China Regenerative Medicine International Limited

8158.HKHKSE
Healthcare
Biotechnology
HK$0.87
HK$-0.09(-9.37%)

China Regenerative Medicine International Limited (8158.HK) Company Profile & Overview

Explore China Regenerative Medicine International Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

China Regenerative Medicine International Limited (8158.HK) Company Profile & Overview

China Regenerative Medicine International Limited, an investment holding company, produces and sells healthcare products and services. The company offers health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services comprising non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate repairing services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.

SectorHealthcare
IndustryBiotechnology
CEOChuang Wang

Contact Information

852 3918 9000
Miramar Tower, Tsim Sha Tsui

Company Facts

34 Employees
IPO DateJul 18, 2001
CountryHK
Actively Trading

Frequently Asked Questions

;